Loading insider details...
Beta
Latest Form 4 (Jun 15, 2026): Grant/Award of 8,325 TGTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 8,325 | n/a |
| Sep 12, 2025 | TG THERAPEUTICS, INC. (TGTX) | Sale | 20,852 | $672.3K |
| Jun 16, 2025 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 14,718 | n/a |
| Nov 12, 2024 | TG THERAPEUTICS, INC. (TGTX) | Sale | 5,000 | $152.2K |
| Jun 20, 2024 | TG THERAPEUTICS, INC. (TGTX) | Sale | 9,585 | $157.1K |
| Mar 15, 2024 | TG THERAPEUTICS, INC. (TGTX) | Sale | 5,000 | $79.7K |
| Sep 29, 2023 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 20,000 | n/a |
| Jun 26, 2023 | TG THERAPEUTICS, INC. (TGTX) | Sale | 34,854 | $814.5K |
| Jul 22, 2022 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 43,732 | n/a |
| Jun 22, 2021 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 20,000 | n/a |